PROFFIT PATIENT REPORTED OUTCOME FOR FIGHTING FINANCIAL TOXICITY OF CANCER Logo (EUIPO, 10/05/2021)
EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark PROFFIT PATIENT REPORTED OUTCOME FOR FIGHTING FINANCIAL TOXICITY OF CANCER was filed as Figurative mark on 10/05/2021 at the European Union Intellectual Property Office.
It was registered as a trademark on 02/04/2022.
The current status of the mark is "Trademark registered".
Logodesign (Wiener Klassifikation)
#Surfaces or backgrounds covered with circles or ellipses #Surfaces or backgrounds covered with dots, spickled, recycled paper-like surfaces
| Trademark form | Figurative mark |
| File reference | 018571535 |
| Application date | October 5, 2021 |
| Publication date | October 28, 2021 |
| Entry date | February 4, 2022 |
| Expiration date | October 5, 2031 |
Trademark owner
Via Mariano Semmola 52
80131 Napoli
IT
80131 Napoli
IT
Trademark representatives
Via Vincenzo Bellini, 20
00198 Roma
IT
goods and services
42
Medical and scientific research; Clinical research; Medical laboratory services; Research services; biomedical research; Scientific research and development; Research on the subject of pharmaceuticals; Medical research; Biological research; Biological research, clinical research and medical research; Research laboratories; Pharmaceutical research services; Pharmaceutical research and development; Scientific research; Research on the subject of pharmaceuticals; Scientific research in the field of pharmacy; Research in the field of pharmacogenetics; Medical and pharmacological research services; Consultancy in the field of scientific research; Research and development for the pharmaceutical industry; Scientific research for medical purposes in the area of cancerous diseases; Research and development in the pharmaceutical and biotechnology fields; Scientific research for medical purposes in the field of cancer; Scientific research for medical purposes in the field of carcinogenic diseases; Design and development of medical technology; Development of pharmaceutical preparations and medicines; Design and development of medical diagnostic apparatus; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
44
Medical clinic services; Medical screening; Medical screening; Medical screening; Medical counseling; Medical assistance; Medical care; Medical screening; Medical counseling; Medical clinic services; Medical diagnostics; Surgical and medical services; Medical examination of individuals; Medical evaluation services; Compilation of medical reports; Provision of medical services; Physician services; Medical counseling; Medical assistance; Medical examinations; Pharmaceutical and medical consultancy; Medical treatment services; Medical clinic services; Issuing of medical reports; Services for the provision of medical facilities; Medical analysis services; Arranging of medical treatment; Medical assistance consultancy provided by doctors and other specialized medical personnel; Medical treatment services; Medical services in the field of oncology; DNA screening for medical purposes; Medical and surgical diagnosis; Medical and healthcare clinics; Medical diagnostic services; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical analysis for the diagnosis and treatment of persons; Medical and health services relating to DNA, genetics and genetic testing; Medical testing services relating to the diagnosis and treatment of disease; Medical analysis services for the diagnosis of cancer and Medical analysis for forecasting the course of the disease; Medical laboratory services for the analysis of blood samples taken from patients; Medical treatment services provided by clinics and hospitals
ID: 11018571535